Abstract:To better define the relative role of metabolic factors in the recurrence of stone formation, we studied the 24-hour urinary excretion of calcium (uCa), citrate (uCit), oxalic acid (uOx) and uric acid (uUa) in 73 male patients with primary calcium oxalate urolithiasis. According to the episodes of stone formation per year, we identified 51 recurrent stone formers (RSF) and 22 single stone formers (SSF). 20 normal adult males constituted the control group (C). uCa and uOx were higher in RSF than in C, but quite… Show more
“…In this study, we also observed a high incidence of calcium oxalate stone: 70.8% in FSF patients and 59.4% in RSF patients. Hypocitraturia was the most common abnormality in this study in both groups, consistent with previous reports [5,17]. Although our data indicate that on the basis of urinary citrate levels, patients with recurrent stone formation cannot be distinguished from patients with 1 episode only, we can assume that urinary citrate is an important risk factor for stone disease.…”
Section: Discussionsupporting
confidence: 93%
“…Despite the introduction of non-invasive techniques for the removal of stones and the identification of several metabolic factors responsible for stone formation [4][5][6], stone recurrence continues to be a significant clinical problem [16]. About 80% of urolithiasis patients have been reported to have calcium oxalate stones [11].…”
Section: Discussionmentioning
confidence: 99%
“…The disease, which has a high incidence of recurrence following treatment, is one of the biggest challenges facing urologists today, partly due to the fact that the pathogenesis of the stone formation is not clearly understood [2,3]. Urolithiasis is a complex process influenced by several factors, including hyperoxaluria, hypercalciuria, hypocitraturia, hyperuricosuria, low urinary volume [4][5][6], anatomical malformations [7], and urinary stasis as well as dietary habits [8]. Recently, detection of Oxalobacter formigenes, a specific oxalate-degrading anaerobic bacterium inhabiting the gastrointestinal tracts of humans, has attracted attention because the absence of this bacterium appears to be a risk factor for development of hyperoxaluria and/or recurrent kidney stone disease [9].…”
Objective: To examine stone composition, metabolic evaluation and colonization of Oxalobacter formigenes as risk factors for renal stone formation. Subjects and Methods: Eighty patients with renal stones and 70 healthy controls were enrolled in the study. Of the 80 patients, 48 were first-time stone formers (FSF) and 32 were ‘recurrent’ stone formers (RSF), recurrent indicating 2 or more episodes of stone formation. Stone analysis by X-ray crystallography, 24-hour urine metabolic profile and detection of O. formigenes-specific DNA by PCR were performed for each patient. Detection of O. formigenes was also performed on 45 and urinary metabolic profile on an additional 25 controls. Results: Calcium oxalate monohydrate was the major component of stones, hyperoxaluria and hypocitraturia were the most common urinary abnormalities in the 80 patients, 46% of RSF patients had hypercalciuria. Urinary abnormalities were far less frequent in the controls, with the exception of hypocitraturia (40%). Of the urinary metabolites, only calcium levels were significantly different (p < 0.05) between FSF (6.50 ± 4.08 mmol/24 h) and RSF (8.21 ± 5.26 mmol/24 h) patients. Colonization of O. formigenes was higher in controls (62.2%) than in FSF (33.3%) or RSF (28%) patients, it was least in patients with more than 4 episodes (7%) of stone formation. Conclusion: The findings indicate that lack of colonization of O. formigenes may be an important risk factor for recurrence of stone formation (calcium oxalate monohydrate).
“…In this study, we also observed a high incidence of calcium oxalate stone: 70.8% in FSF patients and 59.4% in RSF patients. Hypocitraturia was the most common abnormality in this study in both groups, consistent with previous reports [5,17]. Although our data indicate that on the basis of urinary citrate levels, patients with recurrent stone formation cannot be distinguished from patients with 1 episode only, we can assume that urinary citrate is an important risk factor for stone disease.…”
Section: Discussionsupporting
confidence: 93%
“…Despite the introduction of non-invasive techniques for the removal of stones and the identification of several metabolic factors responsible for stone formation [4][5][6], stone recurrence continues to be a significant clinical problem [16]. About 80% of urolithiasis patients have been reported to have calcium oxalate stones [11].…”
Section: Discussionmentioning
confidence: 99%
“…The disease, which has a high incidence of recurrence following treatment, is one of the biggest challenges facing urologists today, partly due to the fact that the pathogenesis of the stone formation is not clearly understood [2,3]. Urolithiasis is a complex process influenced by several factors, including hyperoxaluria, hypercalciuria, hypocitraturia, hyperuricosuria, low urinary volume [4][5][6], anatomical malformations [7], and urinary stasis as well as dietary habits [8]. Recently, detection of Oxalobacter formigenes, a specific oxalate-degrading anaerobic bacterium inhabiting the gastrointestinal tracts of humans, has attracted attention because the absence of this bacterium appears to be a risk factor for development of hyperoxaluria and/or recurrent kidney stone disease [9].…”
Objective: To examine stone composition, metabolic evaluation and colonization of Oxalobacter formigenes as risk factors for renal stone formation. Subjects and Methods: Eighty patients with renal stones and 70 healthy controls were enrolled in the study. Of the 80 patients, 48 were first-time stone formers (FSF) and 32 were ‘recurrent’ stone formers (RSF), recurrent indicating 2 or more episodes of stone formation. Stone analysis by X-ray crystallography, 24-hour urine metabolic profile and detection of O. formigenes-specific DNA by PCR were performed for each patient. Detection of O. formigenes was also performed on 45 and urinary metabolic profile on an additional 25 controls. Results: Calcium oxalate monohydrate was the major component of stones, hyperoxaluria and hypocitraturia were the most common urinary abnormalities in the 80 patients, 46% of RSF patients had hypercalciuria. Urinary abnormalities were far less frequent in the controls, with the exception of hypocitraturia (40%). Of the urinary metabolites, only calcium levels were significantly different (p < 0.05) between FSF (6.50 ± 4.08 mmol/24 h) and RSF (8.21 ± 5.26 mmol/24 h) patients. Colonization of O. formigenes was higher in controls (62.2%) than in FSF (33.3%) or RSF (28%) patients, it was least in patients with more than 4 episodes (7%) of stone formation. Conclusion: The findings indicate that lack of colonization of O. formigenes may be an important risk factor for recurrence of stone formation (calcium oxalate monohydrate).
“…Thus, it may not be the absolute urinary calcium or citrate concentrations that determine the risk of stone formation but rather the relative excess of calcium over citrate. Similarly, Cupisti et al (26) found that stone formers had higher urinary calcium excretion and low citrate excretion, which was more marked in recurrent stone formers. As early as 1976, Welshman and McGeown (14) had found urinary calcium/citrate ratio to be different in normal adult subjects and stone formers but found a difference between the two genders.…”
Hypercalciuria is a common cause for stone formation in children. The aim was to delineate the role of urinary citrate in hypercalciuric children for protection against calcium stone formation. We evaluated random urine calcium, citrate, and creatinine in 149 controls, 78 hypercalciuric nonstone formers, and 34 hypercalciuric children with stone. Urine citrate/creatinine was highest in hypercalciuric nonstone formers 899 Ϯ 351 compared with controls 711 Ϯ 328 and stone formers 595 Ϯ 289 (p Ͻ 0.01 vs. both). Calcium/creatinine ratio was similar in hypercalciuric stone and nonstone formers, but significantly higher than controls. Consequently, urine Calcium/citrate ratio (mg/mg) increased from control 0.17 Ϯ 0.17 to 0.41 Ϯ 0.23 (p Ͻ 0.001) in hypercalciuric nonstone formers, and to 0.65 Ϯ 0.46 in stone formers (p Ͻ 0.001 compared with other groups). Area under receiver operating characteristic curve combined with multilevel risk analyses found calcium/citrate ratio of 0.326 to provide good discrimination between control and stone formers. We found 5th percentile for random urine citrate/creatinine ratio in school-aged children to be 176 mg/g, elevated urinary citrate excretion in hypercalciuric children to be protective against stone formation, and urine calcium/citrate ratio to be a good indicator for risk of stone formation. Whether intervention in hypercalciuric children to lower urine calcium/citrate Ͻ0.326 will provide protection against stone formation needs to be studied. (Pediatr Res 66: 85-90, 2009) T he incidence of urolithiasis in children has increased in recent years (1). The risk factors for urolithiasis commonly observed in children are low urine volume, increased urine calcium excretion, and low normal or decreased urinary citrate level (2). Citrate inhibits the spontaneous nucleation of calcium oxalate, crystal growth of calcium oxalate and calcium phosphate, and the heterogeneous nucleation of calcium oxalate by monosodium urate (3-8). Bisaz et al. (9) reported that citrate is responsible for 50% of the inhibitory activity against calcium phosphate precipitation in normal urine. The inhibitory effect of citrate on calcium oxalate crystal growth and aggregation is also linked to a direct effect on the crystal surface (3,10). Consequently, and because of lack of significant adverse effects, citrate preparations are widely used in subjects with calcium oxalate nephrolithiasis (2,11-13).In adult studies, Welshman and McGeown (14), Hobarth and Hofbauer (15) and Nikkila et al. (16) observed that urine calcium/citrate ratio was able to discriminate between stone formers and control population; the latter exhibiting a significantly lower calcium/citrate ratio. However, it was the impression in the above studies that the clinical use of urine calcium/citrate ratio was limited because of its wide range of variability and the influence of age and gender on urinary excretion of citrate. There is limited data on urine calcium/ citrate ratio in either healthy, hypercalciuric, or stone forming child...
“…Urinary citrate is an inhibitor of crystallization of calcium salts in urine, and studies have linked lower levels of urinary citrate excretion to increased calcium oxalate stone risk [30]. Urinary citrate levels of <2.0 mmol/day in males and <2.5 mmol/day in females are considered abnormal.…”
Renal stone disease covers kidney and lower urinary tract stones caused by a variety of conditions, including metabolic and inherited disorders, and anatomical defects with or without chronic urinary infection. Most cases are idiopathic, in which there is undoubtedly a genetic predisposition, but where environmental and lifestyle factors play an important role. Indeed, it is becoming apparent that renal stone disease is often part of a larger ‘metabolic picture’ commonly associated with type 2 diabetes, obesity, dyslipidaemia, and hypertension. Renal stone disease is a growing problem in the UK (and other developed and developing populations) with a cross-sectional prevalence of ∼1.2%. This means that there are currently ∼720,000 individuals with a history of kidney stones in the UK. Almost 40% of first-time stone formers will form a second stone within 3 years of the first episode if no prophylactic measures are instituted to prevent stone recurrence, since removal or disintegration of the first stone does not treat the underlying cause of stones in the majority of patients. The age of onset is getting younger and the sex ratio (until recently more men than women) is becoming almost even. Metabolic screening remains an important part of investigating renal stone disease, but to the disappointment and frustration of many doctors, medical treatment is still essentially pragmatic, except perhaps in cystinuria, and to a limited extent in primary hyperoxaluria (if pyridoxine-sensitive); although newer treatments may be emerging. This review summarizes current thinking and provides a practical basis for the management of renal stone disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.